Parameter Percentage of the lable claim
Lamidine tablets Nezoral tablets Crixivan capsules
Data 99.45 101.10 101.22
99.50 100.90 100.24
100.33 99.40 99.31
100.20 99.53 100.44
100.63 100.30 99.75
99.82 99.55 100.32
99.60 101.21 99.60
99.12 99.23 99.32
100.15 99.65 99.35
100.30 99.21 99.50
Mean 99.91  100.01 99.90
 SD 0.53 0.80 0.50
% Error 0.17 0.30 0.15
 Acceptance 1.25 1.85 1.10
value(AV)      
Maximum allowed  value(L1) 15
Table 6: Content uniformity testing of Lamivudine, ketoconazole and indinavir in their dosage forms using the proposed method.